June 2026 – Morgan Hill, California: Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has successfully tech-transferred and manufactured the first commercial-scale GMP…
News Category: Press Release
Aragen becomes country’s first and only CRDMO to be recognized among India’s Best Companies to Work For 2026
Retains Its Position Among India’s Top 25 Best Workplaces in Pharmaceuticals, Healthcare & Biotech for the Fourth Year Hyderabad, India, 2nd July, 2026: Aragen Life Sciences,…
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate the Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
Tampa, Florida; Morgan Hill, California — May 19, 2020 — Oragenics, Inc. (NYSE American: OGEN), (the “Company” or “Oragenics”), today announced, that through its wholly-owned…
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process
Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances Tustin, California; Morgan Hill, California —…
Aragen Bioscience and University of Technology, Sydney Enter MoU to Support and Accelerate Biologics R&D in Australia
Morgan Hill, California; Hyderabad, India — March 03, 2020 — Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule…
Aragen Bioscience Announces the Appointment of Steven Lang, PhD, MBA as Vice President, Biologics
The addition of Dr. Lang is part of a multi-year investment in Aragen’s team, facilities and technologies. Morgan Hill, California — February 25, 2020 —…
Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development
San Jose, California, USA; Hyderabad, India — January 08, 2020 — Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading…
GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and the Appointment of Ramesh Subramanian as its New Chief Commercial Officer
Hyderabad, India — September 04, 2019 — GVK BIO, a leading global Contract Research and Development Organisation (CRDO), is pleased to announce the promotion of…
Biological E and GVK BIO Announce Strategic R&D Partnership
Hyderabad, India — July 31, 2019 — GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a…
GVK BIO Announces the Appointment of Robert R. Ruffolo, PhD, to its Board of Directors
Hyderabad, India — July 10, 2019 — GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of…
